SOPHiA GENETICS SA (SOPH), Tuesday announced an expansion of collaboration with AstraZeneca (AZN), expecting to leverage its multimodal AI Factories to generate evidence on the efficacy, value, and real-world impact of therapies for certain types of breast cancer.
Moreover, it will also support the potential development of a bespoke AI-powered predictive model aimed at optimizing outcomes for individuals undergoing treatment for breast cancer.
The expanded partnership is expected to position SOPHiA as a trusted technology partner and underlines its commitment to advancing global health through federated data analytics and artificial intelligence.
In the pre-market hours, SOPH is moving down 4.5 percent, to $3.15 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.